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Abstract
After an initial meeting in 2013 that reviewed adherence to disease modifying therapy, the AD@MS
group conducted a follow-up meeting in 2014 that examined adherence to behavioural interventions in
MS (e.g. physical activity, diet, psychosocial interventions). Very few studies have studied adherence to
behavioural interventions in MS. Outcomes beyond six months are lacking, as well as implementation
work in the community. Psychological interventions need to overcome stigma and other barriers to
facilitate initiation and maintenance of behaviour change. A focus group concentrated on physical
activity and exercise as one major behavioural intervention domain in MS. The discussion revealed that
patients are confronted with multiple challenges when attempting to regularly engage in physical
activity. Highlighted needs for future research included an improved understanding of patients’ and
health experts’ knowledge and attitudes towards physical activity as well as a need for longitudinal
research that investigates exercise persistence.
Keywords: Multiple sclerosis, rehabilitation, adherence, behavioural interventions, exercise, quality of life
Date received: 29 January 2015; accepted: 2 April 2015
Introduction
Adherence to medical interventions is a global prob-
lem, particularly in chronic diseases such as multiple
sclerosis (MS). Participants of a first international
meeting on Adherence in MS (AD@MS) in 2013
under the auspices of the European Rehabilitation
in MS (RIMS) Network concluded that there is a
lack of rigorous and robust research examining
adherence to medication regimens in MS.1 The
group further highlighted the importance of research
examining the preferences, attitudes and needs of
patients regarding behaviour change decisions, and
the importance of investigating the provision of high
quality patient information as a prerequisite for opti-
mal decision making.
The goal of the second AD@MS meeting (5 June
2014) was to summarize the current knowledge of
adherence to behavioural interventions in MS and to
identify core areas for future research. In the 2013
consensus we defined adherence as active agree-
ment, consent and involvement of patients in their
medical treatment. This definition of adherence can
include drug treatments and medically oriented diag-
nostic tests, but also substantial and subtle lifestyle
changes. We now operationally define behavioural
interventions as educational and interactive treat-
ments designed to induce healthy non-pharmacolo-
gic behaviour change. Behavioural interventions that
successfully promote a healthy lifestyle can reduce
the risk and/or severity of many chronic conditions,
including cardiovascular disease, cancer, depression,
dementia and sexually transmitted disease.2
Rehabilitation may be the most complex behavioural
intervention. It is a problem-solving educational
process designed to change behaviour and adherence
to these changes via enhanced activity and health
participation.3 Understanding rehabilitation adher-
ence requires the examination of multiple distinct
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treatment approaches and processes that are commonly
oriented by a set of overlapping goals. Whereas adher-
ence to single components of a rehabilitation process
(e.g. exercise, diet or use of specific self-management
skills) can be studied, examining adherence to the
whole approach presents significant methodological
challenges.
Although adherence is a multi-dimensional
construct, it is often conceptualized as unitary in
drug treatment and behavioural intervention studies.
Multimodal measurement of adherence may be
especially important in behavioural interventions to
obtain a detailed estimate of patient engagement.4
Moreover, the effectiveness of behavioural interven-
tions frequently depends upon the continued
application of newly acquired skills. As such, adher-
ence research is at the core of all behavioural
interventions.
The first part of the second AD@MS meeting
consisted of a series of short presentations by
participants detailing behavioural adherence to psy-
chosocial interventions, diet and exercise. Next, a
structured focus group (n¼ 20) was used to compile
future research prospects for physical activity adher-
ence in MS (for detailed group information see the
participant list below). A list of core questions was
devised by the facilitator (PB) and the focus group
lasted for 90minutes.
Summary of major topics
Diet change and adherence
As evidenced by rising rates of obesity in the western
world, adherence to healthy diets requires substantial
behavioural control. While there is some scientific
agreement surrounding what constitutes optimal
nutrition in the general population,5 there is no spe-
cific consensus in MS. Obesity causes fatigue and
mobility problems in the general population and
worsens mobility symptoms in MS. Moreover, new
data suggest that obesity is associated with disease
onset and symptoms expression. As such, dietary
counselling in MS is highly relevant, but rarely dis-
cussed in the scientific literature. MS patients
commonly seek an array of dietary interventions
and supplements. Although many different diets
such as vitamin D supplementation, low salt, and
ketogenic diets have been touted for their possible
therapeutic effects, current evidence may only justify
supplementation with polyunsaturated fatty acids.6,7
Given the emerging importance of obesity as a risk
factor for developing MS and the value placed on
nutritional supplementation by MS patients, the
paucity of valid studies in this area is possibly
one the most unmet needs in MS lifestyle research.
Studies promoting diets in MS beyond supplemen-
tary interventions are largely absent. With improved
life expectancy, addressing co-morbidities like
obesity becomes increasingly relevant to patients
with MS.
Behavioural interventions to manage
neuropsychiatric symptoms and distress
An increasing number of studies show beneficial
effects of psychosocial interventions to control and
manage common mental health difficulties in MS,
including fatigue, depression and cognitive dysfunc-
tion.810 Despite these successes, psychosocial inter-
ventions generally show drop-out rates from 25% to
75% and lack long-term follow-up data.4 Measuring
adherence to these interventions is a complex
endeavour. In addition to missing appointments out-
right, patients fail to actively engage during, between
or after sessions. In contrast to drug regimens
for chronic disease that typically must be taken indef-
initely, psychosocial interventions may be applied in a
low frequency for a defined number of sessions, some
with occasional follow-up or ‘booster’ sessions. While
session attendance can easily be measured, intra- and
inter-session involvement depends on surrogates such
as questionnaires, interviews and audio/video ratings.
These interventions commonly promote adherence by
using reminder calls, motivational interviewing, SMS
texting, email, motivational enhancement techniques,
and concrete support (e.g. scheduling, transportation).
Homework completion has been shown to contribute
substantially to treatment effects in psychosocial
interventions.11 In addition, promoting a strong thera-
peutic alliance between patients and their providers
based on trust may play a substantial role in fostering
adherence.
Based on the cognitive problems in MS, specific
neuropsychological interventions are increasingly
studied.10 They need to handle not only the stigma
of psychiatric disease but also the stigma of cogni-
tive dysfunction.
Finally, although seldom studied, acceptance-
oriented psychological interventions might improve
openness to behaviour change.
Physical activity
Among other benefits, regular physical activity
and exercise improve functional mobility and overall
quality of life in MS.12 On the other hand, physical
activity rates are reduced in MS leading to concerns
about exercise adherence. Bodily limitations,
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difficulties with service access and limited transpor-
tation are substantial barriers. Exercise studies in MS
have shown as high as 80% adherence rates in the
core study phase13 but data six months or more post
intervention are scarce. Moreover, how adherence is
defined in exercise studies is highly variable and
no gold standard exists for the requisite percentage
of training sessions completed or the amount of in-
session effort required. Implementation of exercise
programmes within the community is one major key
to increasing physical activity among patients with
MS. This can be addressed by identifying theoreti-
cally-based determinants of physical activity (e.g.
self-efficacy or outcome expectations as facilitators
and bodily limitations as impediments) that can then
be targeted by behavioural interventions or inte-
grated into exercise training programmes.
There is limited evidence regarding optimal
approaches for initiating and then maintaining
changes in physical activity and very little research
has been conducted among MS patients with a
progressive course. Various approaches to improving
exercise adherence have been discussed, including
group training, socializing via internet exchanges,
and the application of gaming settings. Health edu-
cation and financial incentives have also been pro-
posed as possible means of improving exercise
adherence. However, more research is needed to
fully ascertain the efficacy of these approaches.
Collectively, these voids in the literature served as
a major impetus for the focus group to discuss exer-
cise and physical activity.
Focus group on adherence to physical activity in MS
The focus group had one facilitator (PB); it lasted for
90minutes, and was audio-recorded. The focus
group data were analysed iteratively for emergent
themes using qualitative interpretative analysis.14
The 20 participants were multidisciplinary (see list-
ing below). Table 1 illustrates the main findings
emerging from the focus group analysis, performed
by PB, JB and CH.
Conclusions
Drug and behavioural therapies both play a major
role in the optimal management of MS. While a
plethora of data suggest short-term effects on
patient-reported outcomes, the long-term impact of
behavioural interventions on psychological
Table 1. Research issues derived from the focus group regarding physical activity (PA), exercise and
adherence.
PA and exercise adherence mechanisms
 There is a need for greater understanding of the mechanisms by which PA and exercise impact on
outcomes ranging from quality of life through MS pathophysiology processes (i.e. inflammation, degen-
eration, progression). Without a better understanding of neurobiologic mechanisms of exercise, fostering
adherence will remain difficult.
 There is a need to design longitudinal studies to understand adherence to PA and exercise over the long
term. This includes selection and application of suitable psychological models that explain health
behaviour change.
 It is acknowledged as a limitation that MS patients with excessive fatigue and/or significant cognitive
deficits have not been included in exercise trials. Although these patients might have specific problems
adhering to the training, they might also experience specific benefits.
Patient focused questions
 What do MS patients know and understand about the importance of PA and exercise in maintaining good
health?
 What priority do MS patients give to physical activity and exercise, given all the other adherence related
issues they need to deal with? What do they expect to result from engaging in a physically active
lifestyle and exercise?
 How do MS patients’ socio-economic and familial/social networks influence perception of and adhere to
exercise interventions?
Health professional focused questions
 What do health care professionals know about the benefits and wider determinants of PA and exercise in
MS, what sources of evidence do they draw on and how are these issues communicated to patients
(especially in more disabled or fatigued patients)?
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wellbeing, symptom management, illness-related
impairment, activity and healthcare participation is
not clear. The group agreed that any large behavioural
intervention study should include maintenance data
beyond month 6 post treatment. In addition, it was
agreed that multiple levels of adherence data should
be obtained and reported for all behavioural trials.
Finally, there was consensus that there is a lack of
information regarding how patients and health profes-
sionals perceive nonadherence to behavioural
interventions.
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